Release Date: 14/06/16 15:38 Summary: Change of Director's Interest Notice-BRB.AX Price Sensitive: No Download Document 72.95KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%